DoMore Diagnostics

DoMore DiagnosticsNOME2023-03-21T09:58:18+00:00

DoMore Diagnostics

Transformation of cancer diagnostics with artificial intelligence

DoMore Diagnostics is a pioneer in utilizing artificial intelligence to increase the prognostic and predictive value of cancer tissue biopsies.

DoMore Diagnostics is based in Oslo, Norway and is headed by the CEO and Co-founder Torbjørn Furuseth.

DoMore Diagnostics joined NOME in 2022.

Company details

Website

Domorediagnostics.com

More companies

MetsystemNOME2024-04-15T10:43:58+00:00

Metsystem
Metsystem

Digital Health
Droplet IVNOME2024-04-15T08:52:38+00:00

Droplet IV
Droplet IV

Medical Devices
Strike PharmaNOME2024-04-15T08:48:25+00:00

Strike Pharma
Strike Pharma

Therapeutics
InossiaNOME2024-04-15T08:43:52+00:00

Inossia
Inossia

Medical Devices
Linio BiotechNOME2024-04-15T08:37:31+00:00

Linio Biotech
Linio Biotech

Medical Devices
BrainCaptureNOME2024-04-15T08:32:40+00:00

BrainCapture
BrainCapture

Digital Health
2N PharmaNOME2024-04-15T08:22:22+00:00

2N Pharma
2N Pharma

Other, Therapeutics
One-Carbon TherapeuticsNOME2024-04-15T08:21:33+00:00

One-Carbon Therapeutics
One-Carbon Therapeutics

Other, Therapeutics

VIEW ALL PROJECTS